It’s unclear how much such a pill would cost, but Novo Nordisk’s Ozempic and Wegovy shots currently go for several hundred ...

The Danish drugmaker said a clinical trial showed participants who got a pill form of Wegovy lost an average of 16.6 percent ...

Positive results from the trial further indicate that the company is poised to win the next battle in the weight loss drug ...

New results from a survey of 550 Wegovy users found patients reported a major drop in "food noise," or intrusive thoughts ...

"That's an easy move to make out of the gate, but it's also unusual at Novo, and it's piqued investor interest," said ...

“It is very encouraging to see these new data from people using Wegovy that, in addition to weight loss, Wegovy may help ...

Novo Nordisk's pill version of Wegovy could be just as effective as the injectable shot, according to new clinical trial data ...

Danish multinational pharmaceutical company Novo Nordisk’s obesity drug Wegovy (semaglutide 2.4 mg) cut risk of heart attack, ...

Novo Nordisk's experimental Wegovy pill showed a 16.6% weight-loss in a late-stage study, according to data published in The ...

A new study conducted in the United States, as reported by Investing.com, has confirmed that Wegovy, a semaglutide-based drug ...

Novo Nordisk's shares rise as Phase III trial shows its oral Wegovy pill achieves significant weight loss, offering a new ...

Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form. Novo Nordisk says its oral semaglutide pill led to "significant weight loss" in a trial.